Jentashapir Journal of Health Research

Published by: Kowsar

Comparison of Levetiracetam With Sodium Valproate in Controlling Seizure in Patients Suffering From Juvenile Myoclonic Epilepsy

Davood Kashipazha 1 , Seyed Ehsan Mohammadiany Nejad 1 , Fatemeh Sadr 1 , * , Shahram Tarahomi 1 and Soroush Sadr 2
Authors Information
1 Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Medical School, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jentashapir Journal of Health Research: August 01, 2014, 5 (4); e21875
  • Published Online: August 11, 2014
  • Article Type: Research Article
  • Received: March 1, 2014
  • Revised: April 12, 2014
  • Accepted: April 27, 2014
  • DOI: 10.17795/jjhr-21875

To Cite: Kashipazha D, Mohammadiany Nejad S E, Sadr F, Tarahomi S, Sadr S. et al. Comparison of Levetiracetam With Sodium Valproate in Controlling Seizure in Patients Suffering From Juvenile Myoclonic Epilepsy, Jentashapir J Helath Res. 2014 ;5(4):e21875. doi: 10.17795/jjhr-21875.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Mantoan L, Walker M. Treatment options in juvenile myoclonic epilepsy. Curr Treat Options Neurol. 2011; 13(4): 355-70[DOI][PubMed]
  • 2. Faught E. Epilepsy case studies. Neurol Clin. 2006; 24(2): 291-307[DOI][PubMed]
  • 3. Auvin S. Treatment of juvenile myoclonic epilepsy. CNS Neurosci Ther. 2008; 14(3): 227-33[DOI][PubMed]
  • 4. Specchio LM, Gambardella A, Giallonardo AT, Michelucci R, Specchio N, Boero G, et al. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy. Epilepsy Res. 2006; 71(1): 32-9[DOI][PubMed]
  • 5. Abou-Khalil BW, Gallagher MJ, Macdonald RL. Neurology in Clinical Practice. 2012; : 1597
  • 6. Auvin S. Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy. Neuropsychiatr Dis Treat. 2007; 3(6): 729-34[PubMed]
  • 7. Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, et al. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Dev Med Child Neurol. 2008; 50(1): 29-32[DOI][PubMed]
  • 8. Montouris G, Abou-Khalil B. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Epilepsia. 2009; 50 Suppl 8: 16-20[DOI][PubMed]
  • 9. Alfradique I, Vasconcelos MM. Juvenile myoclonic epilepsy. Arq Neuropsiquiatr. 2007; 65(4B): 1266-71
  • 10. Sharpe DV, Patel AD, Abou-Khalil B, Fenichel GM. Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure. 2008; 17(1): 64-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments